- Lasker Clinical Research Scholar, Physiology Section
Hans Ackerman studied biology at the College of William and Mary and the Virginia Institute of Marine Science and graduated with a B.S. in 1997. He then attended Magdalen College, Oxford and earned a M.Sc. in Human Biology and a D.Phil. in Human Genetics in 1998 and 2002, respectively, for work on genetic susceptibility to malaria in African children. He returned to the United States to study medicine at Harvard Medical School, and he received his M.D. in 2005. Dr. Ackerman trained in Internal Medicine at the Massachusetts General Hospital from 2005 to 2007. In 2007, Dr. Ackerman joined the NIH as a Critical Care Medicine fellow and became board-certified in Internal Medicine and Critical Care Medicine. From 2010 to 2014 he served as a Clinical Research Fellow and then as an Assistant Clinical Investigator in the Laboratory of Malaria and Vector Research at the National Institute of Allergy and Infectious Diseases, where he studied blood vessel function in patients with malaria or sickle cell disease. In 2014, he joined the NHLBI Sickle Cell Branch where he leads the Physiology Section as a Tenure-Track Investigator and Lasker Clinical Research Scholar.
- (2018). A biomarker approach to syndrome-based treatment of severe childhood illness in malaria-endemic areas. MALARIA JOURNAL. 17,
- (2018). Endothelial cell alpha-globin and its molecular chaperone alpha-hemoglobin-stabilizing protein regulate arteriolar contractility. JOURNAL OF CLINICAL INVESTIGATION. 128(11), 5073-5082.
- (2016). Decreased Rate of Plasma Arginine Appearance in Murine Malaria May Explain Hypoargininemia in Children With Cerebral Malaria. JOURNAL OF INFECTIOUS DISEASES. 214(12), 1840-1849.